Our good friend, Polly Morris heard about VoyageMD and thought there could be material for a song based around all the ups and downs that travellers writhe diabetes face.
We think the song, "It's a Wonder" if excellent - funny, quirky and catchy. See if you agree? Just click on our home page and there it is..
http://www.voyagemd.com/
Soon we will also move into the Journey planning space. We will be able to translate flight information into a planned journey including guidance about blood glucose monitoring as well as all the usual information. The plan is to create an app as well so things are really taking off for VoyageMD.
Watch this space for more information and developments and if you like Polly's song tell us and we will pass this on. If you would like Polly to write a song for your organisation drop me an email at david.kerr@voyagemd.com
Diabetes MD - Everything related to travel and diabetes.
Saturday, 12 November 2011
Tuesday, 1 November 2011
New research studies - blood glucose monitoring
At VoyageMD we have been involved in publishing some new ideas around blood glucose monitoring with American and European colleagues. Here are the links:
http://www.journalofdst.org/November2011/PDF/Abstract/VOL-5-6-CLA1-KERR-ABSTRACT.pdf
http://www.journalofdst.org/November2011/PDF/Abstract/VOL-5-6-REV1-KLONOFF-ABSTRACT.pdf
What do they mean:
Self-monitoring of blood glucose is not easy but the results obtained could be much more valuable for people living with diabetes the results lead to positive action. It is likely that positive action will be possible with the introduction of new technologies:
Device manufacturers could include tools to accomplish the following:
o Systems for supporting behaviour change to help people lose weight
o Using new social media to deliver education and peer support and for providing immediate feedback on a device.
o Translate blood glucose test results into understandable information and advice for diabetes management
o Bolus and basal insulin calculators for patients using multiple daily injections of insulin
o Devices for supporting home monitoring and care at a distance from specialist centres
o Aids for interpretation of SMBG data in the form of pattern recognition of hypoglycemia and/or hyperglycemia recurrence.
o Subsequent developments could include specific prompts for clinicians about potential reasons for these events occurring (e.g., inadequate insulin dosing, wrong time of administration of a bolus dose, or insulin stacking due to too frequent bolus dosing)
Also we need to move away from random measurements of blood glucose to provide a more structured approach such as focusing most of the testing between clinic visits in the 1-2 weeks before seeing the doctor.
The bottom line: SMBG is remains a very good idea provided it is thought through and structured. Random testing just for the sake of it is a waste of money.
http://www.journalofdst.org/November2011/PDF/Abstract/VOL-5-6-CLA1-KERR-ABSTRACT.pdf
http://www.journalofdst.org/November2011/PDF/Abstract/VOL-5-6-REV1-KLONOFF-ABSTRACT.pdf
What do they mean:
Self-monitoring of blood glucose is not easy but the results obtained could be much more valuable for people living with diabetes the results lead to positive action. It is likely that positive action will be possible with the introduction of new technologies:
Device manufacturers could include tools to accomplish the following:
o Systems for supporting behaviour change to help people lose weight
o Using new social media to deliver education and peer support and for providing immediate feedback on a device.
o Translate blood glucose test results into understandable information and advice for diabetes management
o Bolus and basal insulin calculators for patients using multiple daily injections of insulin
o Devices for supporting home monitoring and care at a distance from specialist centres
o Aids for interpretation of SMBG data in the form of pattern recognition of hypoglycemia and/or hyperglycemia recurrence.
o Subsequent developments could include specific prompts for clinicians about potential reasons for these events occurring (e.g., inadequate insulin dosing, wrong time of administration of a bolus dose, or insulin stacking due to too frequent bolus dosing)
Also we need to move away from random measurements of blood glucose to provide a more structured approach such as focusing most of the testing between clinic visits in the 1-2 weeks before seeing the doctor.
The bottom line: SMBG is remains a very good idea provided it is thought through and structured. Random testing just for the sake of it is a waste of money.
Subscribe to:
Posts (Atom)